Finalists Announced for the Medlink East Midlands Business Awards

Fifteen of the best Life Sciences companies from across the East Midlands have been shortlisted for the 2018 Medilink East Midlands Business Awards. The awards ceremony and gala dinner will take place on Wednesday 13 June at The Nottingham Belfry. The business awards celebrate the achievements, breakthroughs and innovations of...

XenoGesis announces expansion plans with move into BioCity’s Discovery Building

Leading DMPK/ADME provider, XenoGesis will be the next tenant to move into BioCity Nottingham’s state-of-the-art Discovery Building, with the support of grant funding from the Government’s Regional Growth Fund and the University of Derby Invest to Grow Programme. XenoGesis is an independent laboratory-based contract research organisation specialised in preclinical drug...

XenoGesis and BioAscent forge alliance to offer enhanced integrated drug discovery services

XenoGesis and BioAscent Discovery Limited have announced a collaboration to offer an enhanced range of integrated drug discovery services, including medicinal chemistry, biology and DMPK. Clients from across the globe will be able to access highly experienced teams specialising in these core drug discovery disciplines. Both companies have outstanding drug...

Pharmaceuticals Business one of the fastest growing in region

Morningside Pharmaceuticals Ltd has once again been named as one of the 200 fastest growing companies in the East Midlands. Professional services network Grant Thornton provides the annual report, which highlights the top performing businesses in Leicestershire, Derbyshire, Nottinghamshire and Lincolnshire. Dr Nik Kotecha OBE, Chief Executive Officer of Morningside...

University of Birmingham forms spin-out to develop new therapeutic target for rheumatoid arthritis

University of Birmingham Enterprise announces the formation of a new spinout company, Viatem Ltd, to develop and exploit the therapeutic potential of PEPITEM (Peptide Inhibitor of Trans-Endothelial Migration). The announcement coincides with the presentation of new research showing that synthetic PEPITEM can prevent or delay the onset of rheumatoid arthritis...

Your innovation deserves recognition

The Medilink Midlands Awards are now open, celebrating outstanding innovation across the region’s medtech and life sciences sector.

With 10 categories to enter, now’s the time to showcase your achievements.
Extended Deadline Date: 16th January

Start your application today.

Almost There! Just Tell Us a Bit About You​

Almost There! Just Tell Us a Bit About You​

Almost There! Just Tell Us a Bit About You​

Almost There! Just Tell Us a Bit About You​

Almost There! Just Tell Us a Bit About You​

Almost There! Just Tell Us a Bit About You​

Almost There! Just Tell Us a Bit About You​

Almost There! Just Tell Us a Bit About You​

Almost There! Just Tell Us a Bit About You​

Almost There! Just Tell Us a Bit About You​

Almost There! Just Tell Us a Bit About You​